International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

F Van Rhee, P Voorhees, A Dispenzieri… - Blood, The Journal …, 2018 - ashpublications.org
Castleman disease (CD) describes a group of heterogeneous hematologic disorders with
characteristic histopathological features. CD can present with unicentric or multicentric …

Anakinra therapy for non-cancer inflammatory diseases

G Cavalli, CA Dinarello - Frontiers in pharmacology, 2018 - frontiersin.org
Interleukin-1 (IL-1) is the prototypical inflammatory cytokine: two distinct ligands (IL-1α and IL-
1β) bind the IL-1 type 1 receptor (IL-1R1) and induce a myriad of secondary inflammatory …

Treating inflammation by blocking interleukin-1 in humans

CA Dinarello, JWM van der Meer - Seminars in immunology, 2013 - Elsevier
IL-1 is a master cytokine of local and systemic inflammation. With the availability of specific
IL-1 targeting therapies, a broadening list of diseases has revealed the pathologic role of IL …

Idiopathic multicentric Castleman's disease: a systematic literature review

AY Liu, CS Nabel, BS Finkelman, JR Ruth… - The Lancet …, 2016 - thelancet.com
Summary Background Multicentric Castleman's disease describes a group of poorly
understood lymphoproliferative disorders driven by proinflammatory hypercytokinaemia …

Inflammasomes in carcinogenesis and anticancer immune responses

L Zitvogel, O Kepp, L Galluzzi, G Kroemer - Nature immunology, 2012 - nature.com
In the complex interplay between malignant cells and their microenvironment, caspase-1
activation complexes (inflammasomes) have contrasting roles. Inflammasomes may operate …

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy

DC Fajgenbaum, F van Rhee… - Blood, The Journal of the …, 2014 - ashpublications.org
Multicentric Castleman's disease (MCD) describes a heterogeneous group of disorders
involving proliferation of morphologically benign lymphocytes due to excessive …

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

DC Fajgenbaum - Blood, The Journal of the American Society …, 2018 - ashpublications.org
Castleman disease (CD) describes a heterogeneous group of hematologic disorders that
share characteristic lymph node histopathology. Patients of all ages present with either a …

Clinical and pathological characteristics of HIV-and HHV-8–negative Castleman disease

LI Yu, M Tu, J Cortes, ZY Xu-Monette… - Blood, The Journal …, 2017 - ashpublications.org
Castleman disease (CD) comprises 3 poorly understood lymphoproliferative variants
sharing several common histopathological features. Unicentric CD (UCD) is localized to a …

Use of a claims database to characterize and estimate the incidence rate for Castleman disease

N Munshi, M Mehra, H van de Velde, A Desai… - Leukemia & …, 2015 - Taylor & Francis
Castleman disease (CD) is a rare lymphoproliferative disorder affecting single (unicentric;
UCD) or multiple (multicentric; MCD) lymph nodes. The incidence of this difficult to diagnose …

Castleman's disease: systematic analysis of 416 patients from the literature

N Talat, KM Schulte - The oncologist, 2011 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Describe the centricity and histopathology profiles of each of the three classes of HIV …